Infectious Disease Clinical Trial
Official title:
Community Based Interventions to Reduce Neonatal Mortality in Bangladesh
This project delivers, promotes and facilitates services related to pregnancy, delivery and newborn care.
The Project entitled "Community-Based Intervention to Reduce Neonatal Mortality in
Bangladesh", also known as Projahnmo - I (Project to Advance the Health of Newborns and
Mothers), is a partnership project of the Johns Hopkins Bloomberg School of Public Health
(JHSPH), USA, with a number of Bangladeshi organizations including: a) the Ministry of
Health and Family Welfare (MOHFW) of the Government of Bangladesh (GoB), b) the Centre for
Health and Population Research (ICDDRB), c) Save the Children/USA, Bangladesh Field Office
(SC/BFO), d) Shimantik, a Bangladeshi NGO, e) BRAC/Bangladesh, f) Dhaka Shishu Hospital and
g) the Institute of Child and Mother Health (ICMH). The project is funded through four
mechanisms: 1) USAID Global funding to cover expenses of JHSPH to design and to provide
technical assistance in the implementation and evaluation of the various components of the
project, 2) SNL/SC funding to JHSPH to sub-contract the Bangladeshi institutions listed
above to support implementation of the intervention component of the project, 3)
USAID/Bangladesh funding to ICDDRB to cover the cost of implementation of the research and
evaluation component of the project, 4) the Bangladeshi government's contribution in-terms
of staff time, supplies, and facilities. This partnership between multiple research
institutions and donors brings diverse, rich and unique experiences and expertise. It
ensures the relevance of the project and increases the likelihood of scaling up and
sustaining the intervention.
The goals of Projahnmo I are to: (a) introduce two models of delivering improved maternal
and newborn care in rural Bangladesh; (b) measure each model's impact on neonatal mortality
and other relevant indicators; (c) assess the cost effectiveness and feasibility of the two
models.
The project includes two intervention arms with two different service delivery models, home
care (HC) and clinic care (CC). Community health workers (CHWs) and community mobilizers
(CMs) deliver the Birth and Newborn Care Preparedness (BNCP) package, which includes
counseling during the antenatal period, delivery care, care of the baby during delivery,
postnatal care, and continued counseling and education during the neonatal period. Service
provision also includes making referral for sick newborns and playing the role of
facilitator for behavior change in the households and communities. The strategic approaches
used also include pregnancy surveillance and community-level mobilization of specific target
groups, such as pregnant women, senior female family members, husbands and other targeted
local advocacy meetings. In both arms, community-based meetings conducted by CMs focus on
facilitating involvement of the mothers and other family members in the decision-making
process and making them aware of the importance of proper antenatal care, delivery care,
postpartum care, and newborn care. In the HC model, counseling is conducted at home with
pregnant women and their families by CHWs. In the CC arm, women receive these messages
through community meetings by CMs and during antenatal check-up (ANC) visits by governmental
primary health workers and paramedics. In CC arms, CMs identify community change agents to
assist in creating awareness and promoting behavior change. In addition, traditional birth
attendants (TBAs), who commonly attend home deliveries in the study communities, have been
oriented on newborn health.
;
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05568953 -
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity
|
Phase 2 | |
Completed |
NCT04568889 -
Minnesota COVID-19 Testing Project
|
N/A | |
Completed |
NCT06063330 -
Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects
|
Phase 1 | |
Completed |
NCT01198925 -
Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion
|
Phase 4 | |
Completed |
NCT05063812 -
Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
|
||
Not yet recruiting |
NCT03636711 -
Antibiotic Stewardship in Infectious Disease Departement
|
||
Completed |
NCT03457688 -
Effect of Prebiotic Fructans to Reduce Number of Febrile Infections in Children
|
N/A | |
Completed |
NCT03241355 -
Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children
|
N/A | |
Terminated |
NCT05420077 -
Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273
|
Phase 1 | |
Completed |
NCT04084106 -
Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota
|
Phase 4 | |
Recruiting |
NCT05013944 -
AnovaOS Network Powered Patient Registry
|
||
Completed |
NCT03893279 -
Perception of Smell and Taste During Antibiotic Treatment
|
||
Active, not recruiting |
NCT05619770 -
Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects
|
Phase 1 | |
Completed |
NCT01772901 -
Brief Influenza Vaccine Education to Pregnant Women
|
N/A | |
Completed |
NCT05413772 -
Temocillin in ESBL-Enterobacteriaceae Infections
|
||
Completed |
NCT04319328 -
Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
|
||
Completed |
NCT04613271 -
Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia
|
Phase 3 | |
Completed |
NCT03239665 -
Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
|
N/A | |
Completed |
NCT03224026 -
Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source
|
||
Not yet recruiting |
NCT06102070 -
Genetic Susceptibility to Severe Infections
|